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Abstract
Introduction: Loss of adult stem cell function during aging contributes to impaired tissue regeneration. Here, we
tested the aging-related decline in regeneration potential of adult stem cells residing in the skeletal muscle.
Methods: We isolated muscle-derived stem/progenitor cells (MDSPCs) from progeroid Zmpste24-deficient mice
(Zmpste24-/-) with accelerated aging phenotypes to investigate whether mutation in lamin A has an adverse effect
on muscle stem/progenitor cell function.
Results: Our results indicate that MDSPCs isolated from Zmpste24-/- mice show reduced proliferation and
myogenic differentiation. In addition, Zmpste24-/- MDSPCs showed impaired muscle regeneration, with a limited
engraftment potential when transplanted into dystrophic muscle, compared with wild-type (WT) MDSPCs. Exposure
of progeroid Zmpste24-/- MDSPCs to WT MDSPCs rescued the myogenic differentiation defect in vitro.
Conclusions: These results demonstrate that adult stem/progenitor cell dysfunction contributes to impairment of
tissue regeneration and suggest that factors secreted by functional cells are indeed important for the therapeutic
effect of adult stem cells.
Introduction
Hutchinson-Gilford progeria syndrome (HGPS) is an
autosomal dominant disease that involves premature
aging, causing early death in childhood due to stroke or
myocardial infarction. The patients have sclerotic skin,
joint contractures, bone abnormalities, and growth
impairment [1]. A point mutation of the lamin A gene
(LMNA), which encodes lamin A protein, was found to
be the main cause of HGPS [2,3]. Lamin A is a nuclear
envelope protein that gives structural support to the
nucleus and is involved in various cellular roles, such as
gene expression and DNA replication [4,5].
Murine models of HGPS have been created by
altering posttranslational modification steps of lamin A
[6-8]. Young and colleagues [6] developed Zmpste24
knockout mice with many features common to HGPS [6].
ZMPSTE24 is a metalloproteinase required for cleaving
the carboxylic group of prelamin A to create lamin A. By
knocking out Zmpste24, prelamin A accumulates on the
cell nuclear envelope, resulting in cellular blebbing [9,10].
The Zmpste24-/- mice display accelerated aging, loss of
weight, spontaneous bone fracture, cardiomyopathy, mus-
cular dystrophy, muscle atrophy, and muscle weakness
[6,7,9,11]. A recent study provides evidence that the skele-
tal muscles of Zmpste24-/- mice exhibit impaired muscle
contraction and neuromuscular performance [11].
Prelamin A has been shown to be involved in early steps
of C2C12 myoblasts differentiation [12]. C2C12 myoblasts
expressing mutated lamin A have also demonstrated a
reduced capacity to undergo myogenic differentiation [13].
Downregulation of lamin A/C levels in myoblasts, by
transfecting them with a mutant Lmna gene, isolated from
Lmna-knockout mice, or from silencing RNA targeting
A-type lamins, showed impaired differentiation kinetics
and reduced differentiation potential [14,15]. These data
provide evidence for a critical role of prelamin A in the
early steps of muscle cell differentiation.
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MDSPCs are an important population of adult stem
cells isolated from skeletal muscle by using a modified
preplate technique [16,17]. They show self-renewable
potential and multilineage differentiation for myogenic,
osteogenic, chondrogenic, and adipogenic lineages in
vitro [16,18-21]. Prominent muscle regeneration has been
observed with MDSPCs transplantation into a dystrophin
knockout mouse model of Duchenne muscular dystrophy
(mdx) [16,22,23]. Although adult stem cells play essential
roles in maintaining tissue and organ function with self-
renewal and multilineage differentiation potential, they
also show age-dependent changes, such as decline in
number and function similar to other somatic cells [24].
Given that stem cell exhaustion and loss of function with
age may limit their muscle-regeneration potential, we
investigated the impact of aging on MDSPC function by
using progeroid Zmpste24-deficient mice, which exhibit
accelerated aging and mimic HGPS.
Methods
Zmpste24-/- mice
Zmpste24-/- genotyping was performed with polymerase
chain reaction (PCR) with oligonucleotides forward:
5’-TCACATGGAGTGAATGCTCTG-3’ and reverse:
5’-AGTGAACACCAGGCCAGTTT-3’ [6]. All animal
experiments were performed in accordance with the
Institutional Animal Care and Use Committee of the
University of Pittsburgh.
MDSPC isolation
MDSPCs were isolated from 8-week-old Zmpste24-/- mice
and WT littermates by using a modified preplate techni-
que according to a previously established protocol [16,17].
MDSPCs were cultured in proliferation medium (PM)
containing Dulbecco’s modified Eagles medium (DMEM,
high glucose) supplemented with 10% horse serum, 10%
fetal bovine serum (FBS), 1% penicillin-streptomycin (all
from Invitrogen, Grand Island, NY, USA), and 0.5% chick
embryo extract (Accurate Chemical, Westbury, NY, USA),
on collagen type I-coated flasks (Sigma-Aldrich, St. Louis,
MO, USA). Cells were used between passages 20 and 30.
Proliferation in vitro
The population doubling time (PDT) over a 72-hour per-
iod was measured from time-lapse images acquired
through a live-cell imaging (LCI) system (Automated Cell
Technologies, Inc., Pittsburgh, PA, USA), as previously
described [25,26]. In brief, cells were plated at an initial
density of 2,000 cells/well in collagen type I-coated
24-well plates, and images were acquired at 15-minute
intervals over a period of 3 days by using an LCI system
equipped with a 10× objective. Five images at each time
point were randomly selected and analyzed, by using
Image J software (v. 1.44p; National Institutes of Health,
Bethesda, MD, USA), from three independent experiments
on three distinct cell lines in each group.
Myogenic differentiation in vitro
MDSPCs were seeded onto collagen type I-coated six-well
plates (1 × 105 cells/well) and cultured for 2 days in PM.
Myogenic differentiation was induced by replacing the PM
with differentiation media (DMEM, 2% FBS, 1% penicillin-
streptomycin) and cultured for 3 days. Immunostaining
for fast myosin heavy chain (f-MyHC), a marker of term-
inal myogenic differentiation, was performed to stain dif-
ferentiated muscle cells. Cells were fixed with -20°C
methanol, blocked with 5% goat serum, and incubated at
room temperature with primary mouse anti-MyHC fast
(1:250; Sigma-Aldrich) and secondary biotinylated IgG
(1:250; Vector Laboratories, Burlingame, CA, USA) each
for 1 hour, and streptavidin-594 (1:500; Sigma-Aldrich) for
15 minutes. The nuclei were visualized by staining with
DAPI (4’, 6’ diamidino-2-phenylindole, 100 ng/ml; Sigma-
Aldrich) for 10 minutes. Fluorescent images were taken by
using a Leica DMIRB inverted microscope equipped with
a QImaging Retiga digital camera with Northern Eclipse
software (v. 6.0; Empix Imaging, Inc., Cheektowaga, NY,
USA). Total cell nuclei and nuclei within f-MyHC-positive
myofibers, from at least 15 fields, each from three replica
platings, were counted by using ImageJ. The myogenic dif-
ferentiation was calculated as percentage of cells expres-
sing f-MyHC (red) per total nuclei (DAPI, blue).
Western blot
MDSPCs from WT and Zmpste24-/- were lysed in Radio-
Immunoprecipitation Assay (RIPA) buffer (Sigma-
Aldrich). Protein concentration was measured with the
Bradford protein assay reagent (Bio-Rad, Hercules, CA,
USA). Equal amounts of protein from each sample were
loaded on 10% SDS-polyacrylamide gels and run for
2 hours at 100 volts. Proteins were then transferred for
60 minutes by 100 volts to a nitrocellulose membrane
(Millipore, Billerica, MA, USA) and blocked by 5% nonfat
dry milk (Bio-rad) in Tris-buffered saline Tween-20
(TBST) for 1 hour. Samples were probed with goat N-
terminal anti-lamin A/C (1:200, sc-6215), goat C-terminal
anti-prelamin A (1:200, sc-6214), and rabbit anti-b-actin
(1:200, all from Santa Cruz Biotechnology, Inc., Dallas,
TX, USA), overnight at 4°C. After washing 3 times with
TBST, the membrane was incubated with secondary anti-
body rabbit anti-goat IgG (H&L) coupled to horseradish
peroxidase (HRP; Santa Cruz Biotechnology, Inc.) and
mouse anti-rabbit IgG-HRP for 1 hour at room tempera-
ture. Blots were developed by using a SuperSignal West
Femto with enhanced chemiluminescent substrate
(1:100,000; Thermo Scientific, Rockford, IL, USA), and the
bands were detected on x-ray film.
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Reverse transcriptase polymerase chain reaction (RT-PCR)
RNA was extracted from cultured cells by using TRIzol
(Invitrogen) and a RNeasy Mini kit (Qiagen Inc., Hilden,
Germany). The amount of RNA yield was quantified by
using a Nano-Quant (Tecan, San Jose, CA, USA), and a
total of 1 μg of RNA was reverse-transcribed into cDNA
by using the Superscript III Reverse Transcriptase (Invitro-
gen), according to the manufacturer’s instructions. Then,
cDNA was mixed with GoTaq polymerase, dNTPs, and
green GoTag reaction buffer (Promega, Madison, WI,
USA) and amplified on a thermal cycler (Eppendorf Mas-
tercycler proS), according to the manufacturer’s instruc-
tions for 30 cycles at 58°C annealing temperature. PCR
products were separated by using 2% agarose gels with 1%
ethidium bromide. The gel images were captured with a
BioRad Gel Doc system. The following primers were used:
Stem cell antigen-1 (Sca-1), forward 5’-CCTACTGTGTG-
CAGAAAGAGC-3’ and reverse 5’-CAGGAAGTCTT-
CACGTTGACC-3’; CD34, forward 5’-GCAGCTTTGAG
ATGACATCACC-3’ and reverse 5’-CTCAGCCTCCTC
CTTTTCACA-3’; myogenin, forward 5’-CTACAGGCCT
TGCTCAGCTC-3’ and 5’-TTGTGGGCGTCTGTAGG-
3’; desmin, forward 5’-AACCTGATAGACGACCTGC
AG-3’ and reverse 5’-GCTTGGACATGTCCATCTCCA-
3’. b-actin, forward 5’-GGGTCAGAAGGACTCCTATG-3’
and reverse 5’-CTTTGATGTCACGCAGCACGATT-3’
was used as a loading control.
Coculture experiments
Zmpste24-/- MDSPCs were plated in the lower compart-
ment of Costar Transwell Permeable Supports (Corning,
Tewksbury, MA, USA) in PM at a density of 3,000 cells/
well in a 24-well collagen type I-coated plate. WT
MDSPCs were seeded into 6.5-mm transwell membrane
inserts at the same density in PM and placed above the
Zmpste24-/- MDSPCs. The 24-well plates containing the
transwells were then placed in the LCI system for
72 hours to measure proliferation of the Zmpste24-/-
MDSPCs, as described earlier. As a control, each plate
contained wells of Zmpste24-/- MDSPCs with empty trans-
well membrane inserts. To measure the differentiation
potential of Zmpste24-/- MDSPCs after coculture, trans-
well inserts were removed after 72 hours, and the PM
media was switched to differentiation media. After 2 to
3 days, myogenic differentiation of the cells was tested by
immunostaining for f-MyHC, as described earlier. Changes
in differentiation potential of Zmpste24-/- MDSPCs was
also tested by using conditioned media from the WT
MDSPCs. WT MDSPCs were cultured for 2 days in
25 cm2 collagen-coated flasks and were then treated with
differentiation media for 3 days. The supernatant was col-
lected and used as conditioned media for 8-week-old
Zmpste24-/- MDSPCs, whereas unconditioned differentia-
tion media was used as a control.
Cell transplantation
The 3 × 105 donor MDSPCs isolated from WT or
Zmpste24-/- mice were intramuscularly transplanted into
the gastrocnemius muscles of 8- to 9-week-old mdx/SCID
mice (C57BL/10ScSn DMDmdx/J/CB17-Prkdcscid/J; The
Jackson Laboratory), an animal model of Duchenne mus-
cular dystrophy that is also immunocompromised. Mice
were killed 2 weeks after transplantation, and the gastro-
cnemius muscles (n = 3) were harvested, frozen in
2-methylbutane pre-cooled in liquid nitrogen, and cryosec-
tioned (10 μm). Sections were immunostained for dystro-
phin, the cross-sectional area of dystrophin-positive
myofibers was measured, and the distribution of the fiber
areas was plotted as previously described [27,28].
Statistical analysis
Statistical analyses were carried out by using Sigmastat
(Jandel Scientific, v. 2.0, San Rafael, CA, USA) software
package. The Student’s t test or Mann-Whitney Rank
Sum test was used for direct comparisons between
groups. For multiple comparisons, the one-way ANOVA
or the Kruskal-Wallis one-way ANOVA on ranks was
applied. Pairwise multiple comparisons were performed
by using the Tukey’s Test after rank-based ANOVA. All
values are expressed as the mean ± SD, and P < 0.05 was
considered significant.
Results
MDSPCs from accelerated aged mice show defect in
prelamin A processing and stem cell marker expression
To determine whether a defect in lamin A/C processing,
previously reported in Zmpste24-deficient mice [7,10],
affects our stem/progenitor cells, MDSPCs isolated from
8-week-old WT and Zmpste24-deficient mice were evalu-
ated for expression and distribution of lamin A/C and pre-
lamin A (Figure 1A). An antibody specific to prelamin
A and lamin A/C revealed accumulation of prelamin Aand
an absence of lamin A expression in the Zmpste24-/-
MDSPCs in comparison with WT MDSPCs. These results
confirm the lack of prelamin A processing in Zmpste24-
deficient MDSPCs, as previously reported in other cells
isolated from these mutant mice [9,29]. Stem cell potential
was also investigated by measuring the expression levels of
CD34 and Sca-1 for each cell population [27]. Zmpste24-
deficient MDSPCs show relatively lower expression levels
of CD34 compared with WT MDSPCs; however, the
expression levels of Sca-1 were similar in both groups
(Figure 1B).
Zmpste24-/- MDSPCs show slower proliferation
Proliferation kinetics of MDSPCs isolated from WT and
Zmpste24-deficient mice was measured in vitro by using an
LCI system, and their numbers per image were manually
counted. Analysis of images showed that the proliferation
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rate of WT and Zmpste24-/- MDSPCs were similar for the
first 24 hours (Figure 1C). However, Zmpste24-/- MDSPCs
started to show a trend toward a reduction in proliferation
rate after 48 hours, which became significant at 72 hours
compared with WT MDSPCs (*P < 0.05, Figure 1C). These
data demonstrate that the proliferation capacity of
MDSPCs diminishes in Zmpste24-deficient mice, as
observed in aged MDSPCs [30].
Zmpste24-/- MDSPCs display limited myogenic
differentiation capacity
To determine whether the myogenic differentiation capa-
city of Zmpste24-/- MDSPCs is affected, the expression
levels of essential proteins that play critical roles in regulat-
ing at least one component of myogenic terminal differen-
tiation were investigated. Myogenin is a muscle-specific
transcription factor involved in functional skeletal muscle
development and is expressed mainly in intermediate
stages of myogenesis [31]. Desmin is expressed at early
stages of myogenic differentiation and continuously
expressed near to terminal myogenesis [32]. Interestingly,
the expression levels of myogenin and desmin were similar
in Zmpste24-/- MDSPCs compared with control WT
MDSPCs, indicating that MDSPCs from aged mice have
similar myogenic potential at the transcriptional level
(Figure 2A). To test whether impairment may occur during
the posttranslational step of myogenesis, cells were cul-
tured to confluence and switched to differentiation media,
and immunostained for the terminal myogenic differentia-
tion marker, f-MyHC. The WT MDSPCs fused to form
elongated multinucleated myotubes expressing f-MyHC,
whereas Zmpste24-/- MDSPCs formed significantly fewer
and smaller myotubes, indicating impaired differentiation
(*P < 0.001, Figure 2B, C). Collectively, these data establish
that the function of the MDSPCs is compromised in
Zmpste24-/- mice, as observed in old WT MDSPCs [30].
Zmpste24-/- MDSPCs show limited muscle regeneration
To investigate the myogenic potential of progeroid
Zmpste24-/- MDSPCs in vivo, 3 × 105 viable MDSPCs iso-
lated from WT and Zmpste24-/- mice were injected into
the gastrocnemius muscle of 8-week-old mdx/SCID mice, a
mouse model of Duchenne muscular dystrophy that lacks
dystrophin at the sarcolemma of muscle fibers [33] and is
also immunoincompetent. The average number of regener-
ated dystrophin-positive myofibers did not significantly
differ between the WT (625, n = 3) and Zmpste24-/- (508,
n = 3) MDSPCs (P = 0.80). However, a dramatic difference
was noted in the average cross-sectional area of the regen-
erated myofibers in mice injected with Zmpste24-deficient
MDSPCs compared with WT MDSPC-injected mice
(Figure 3A). Most of the regenerated myofibers from the
WT MDSPC transplantations had an area of > 500 μm2,
indicative of significantly more mature regenerated myo-
fibers. Conversely, dystrophin-positive myofibers in mice
injected with Zmpste24-/- MDSPCs predominantly had
an area of ≤ 500 μm2 (*P < 0.001, Figure 3B). Dystrophin-
positive centronucleated myofibers of small size regener-
ated by Zmpste24-/- MDSPC transplantation are perhaps
Figure 1 Prelamin A processing, stem cell marker expression, and
proliferation potential are affected in Zmpste24-deficient muscle-
derived stem/progenitor cells (MDSPCs). (A) Immunoblot analysis
to measure the expression of the C-terminal prelamin A and N-
terminal lamin A/C in WT and Zmpste24-/- MDSPCs relative to b-Actin.
(B) RT-PCR to measure expression of stem-cell markers, CD34 and Sca-
1, in MDSPC populations (n = three to four cell populations per group).
(C) Proliferation of MDSPC populations was measured with a live cell-
imaging system for 72 hours. Plotted are averages of normalized cell
numbers at each time point calculated from the analysis of three cell
populations per group, ± SD. *P < 0.001, Mann-Whitney Rank Sum test.
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due to fusion of donor cells with one another or with smal-
ler host-regenerated myofibers. Collectively, the data in
Figures 2 and 3 support the conclusion that the loss of
stem cell function in the Zmpste24-deficient model of
accelerated aging limits muscle regeneration.
WT MDSPCs rescue the myogenic differentiation defect of
Zmpste24-/- MDSPCs
Next, we tested whether WT MDSPCs can restore the
myogenic dysfunction of Zmpste24-/- MDSPCs. MDSPCs
isolated from Zmpste24-deficient mice were cocultured
with the WT MDSPCs by using a transwell system, or in
the presence of conditioned media from WT MDSPCs,
and were switched to low-serum media to evaluate the
myogenic differentiation. Zmpste24-/- MDSPCs tend to
fuse and form spheres (f-MyHC-positive) containing single
or many nuclei (DAPI) (Figure 4A). In contrast, by using
the conditioned media from WT MDSPCs or after cocul-
turing the Zmpste24-/- MDSPCs with WT MDSPCs, nor-
mal myotube formation was restored, indicated by
numerous elongated multinucleated myotubes generated
by the rescued Zmpste24-/- MDSPCs (Figure 4A). The dif-
ferentiation defect was reported by using the observation
that Zmpste24-/- MDSPCs formed more mononucleated
and immature myotubes (myotubes containing two to
three nuclei and expressing f-MyHC) compared with WT
MDSPCs forming more mature myotubes (containing four
or more nuclei; *P < 0.05). Analyzing the type of f-MyHC-
expressing myotubes revealed a significant shift in the dis-
tribution to more mature myotube formation when
Zmpste24-/- MDSPCs were grown in the presence of the
conditioned media isolated from WT MDSPC cultures
(#P < 0.05, relative to WT MDSPCs) or cocultured with
transwells containing the WT MDSPCs (§P < 0.05) relative
to Zmpste24-/- MDSPCs alone or WT MDSPCs (Figure
4B). Thus WT MDSPCs were able to rescue, at least in
part, the myogenic differentiation capacity of MDSPCs iso-
lated from Zmpste24-/- progeroid mice.
Discussion
Numerous studies have reported that mutation of lamin A,
a major component of the nuclear envelope, has an
adverse effect on skeletal muscle function and myoblast
differentiation [7,9,11-14,34]; however, no studies exam-
ined earlier muscle stem/progenitor cells residing in mus-
cle tissue. Because degenerative changes associated with
progeroid syndromes may have a strong impact on stem
cells, we hypothesized that the dysfunction of muscle
stems cells in Zmpste24-/- progeroid mice may contribute
to the loss of the cells’ ability to regenerate skeletal muscle.
To evaluate this hypothesis, we isolated MDSPCs from
Zmpste24-/- mice showing nuclear lamina defects with
accelerated aging phenotypes. Our results show that
expression of stem cell markers decreased in MDSPCs iso-
lated from skeletal muscle of Zmpste24-/- progeroid mice
in comparison with their WT littermates. Furthermore,
MDSPC proliferation and myogenic differentiation was
significantly impaired in Zmpste24-/- MDSPCs relative to
Figure 2 Myogenic differentiation potential is reduced in
Zmpste24-/- muscle-derived stem/progenitor cells (MDSPCs). (A)
RT-PCR to measure the expression of the myogenic differentiation
markers, myogenin and desmin. (B) Representative images of in
vitro MDSPC myogenic differentiation. MDSPC populations were
grown to confluence and then switched to differentiation media.
After 2 to 3 days, cells were immunostained for the terminal
differentiation myogenic marker, f-MyHC (red). Scale bar, 100 μm.
(C) Graph shows the myogenic differentiation (percentage of cells
(DAPI, blue) expressing f-MyHC (red)) of MDSPCs isolated from
Zmpste24-/--deficient mice relative to young WT MDSPCs. Error bars
indicate SD. *P < 0.001, Student’s t test. Representative images are
shown from three separate experiments using three independent
MDSPC populations of each group.
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MDSPCs isolated from WT mice. This is consistent with
our recent findings using naturally aged and excision
repair cross-complementation group 1 (ERCC1)-deficient
mice, a mouse model of progeroid syndrome, indicating
that MDSPCs isolated from aged and progeroid mice
showed loss-of-stemness properties including proliferation
and multilineage differentiation [30]. A recent report also
showed an alteration in the number and proliferation
capacity of epidermal stem cells in Zmpste24-/- progeroid
mice [29]. Similar parallels were found in the vascular
smooth muscles and mesenchymal stem cells (MSCs)
compartment of induced pluripotent stem cells (iPSCs)
Figure 3 Muscle regeneration of progeroid Zmpste24-/- muscle-derived stem/progenitor cells (MDSPCs) is impaired in vivo. To measure
MDSPC function in vivo, WT and Zmpste24-/- MDSPCs were injected into the gastrocnemius muscle of 8-week-old mdx/SCID mice. (A)
Representative images of sections of gastrocnemius muscle from dystrophic mice 14 days after injection immunostained for dystrophin (red) to
identify regenerated myofibers. Scale bar, 100 μm; inset, 50 μm. (B) Quantification of the cross-sectional area of > 1,500 dystrophin-positive
myofibers per group. The distribution of fiber size is indicated on the x-axis, representing increasingly more mature fibers with increased size (*P
< 0.001; Mann-Whitney Rank Sum test at each size range except 100 to 200). Graph represents the results from injection of three to four mdx/
SCID mice with three independent MDSPC populations per group.
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from HGPS dermal fibroblasts [35]. Similarly, molecular
and cellular identity, including the differentiation poten-
tial, were altered in human MSCs (hMSCs) isolated from
HGPS patients [36].
Interestingly, the expression levels of myogenic markers,
myogenin, and desmin, were not affected in MDSPCs iso-
lated from Zmpste24-/- mice, whereas the terminal myo-
genic differentiation marker, f-MyHC, was significantly
impaired. This suggests that the dysfunction of MDSPCs
is most likely due to changes in the posttranscriptional
stages of myogenic differentiation. Recent studies sug-
gested important findings regarding different signaling
pathways involved in the regulation of stem-cell function.
Signaling pathways essential for the maintenance of stem
cell fate and function, such as Wnt in epidermal cells and
microphthalmia transcription factor (Mitf) in melanocytes,
has been shown to be defective in Zmpste24-/- mice [29].
Lineage-specific differentiation of hMSCs was altered
through the activation of the Notch signaling pathway, a
pathway known to regulate stem-cell differentiation [36].
Therefore, future studies are necessary to elucidate the
role of lamin A and possible changes in the signaling
pathways of MDSPCs isolated from Zmpste24-/- progeroid
mice.
Our transplantation study showed that the muscle-
regeneration potential of Zmpste24-/- MDSPCs was sig-
nificantly reduced in comparison to MDSPCs isolated
from WT mice. This supports our hypothesis that loss of
stem-cell function diminishes their regenerative poten-
tial. These results also agree with our recent findings that
muscle from aged and progeroid ERCC1-deficient mice
had significantly reduced regenerative capacity after
Figure 4 Myogenic differentiation defect of Zmpste24-/- muscle-derived stem/progenitor cells (MDSPCs) is rescued in vitro .
(A) Representative images of myotube formation by Zmpste24-/- MDSPCs, Zmpste24-/- MDSPCs in the presence of culture media from WT
MDSPCs, or cocultured with WT MDSPCs by using transwell inserts, f-MyHC (red); nuclear counterstain (DAPI; blue). Scale bar, 100 μm. (B) Plotted
is the percentage of nuclei positive for f-MyHC in mononucleated (*P < 0.05; Tukey’s test, relative to Zmpste24-/- MDSPCs and WT MDSPCs),
myotubes containing two to three nuclei (immature, #P < 0.05; Tukey’s test, in comparison with Zmpste24-/- MDSPCs), and equal to or greater
than four nuclei (mature, §P < 0.05; Tukey’s test, relative to Zmpste24-/- MDSPCs and WT MDSPCs) in each group. Error bars, SD.
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cardiotoxin-induced injury [30]. This is consistent with
the notion that defects in the adult stem-cell compart-
ment, which accrue over time, contribute to the loss of
tissue-regeneration capacity and homeostasis associated
with aging. In addition to the cell-intrinsic defect, local
microenvironment/niche and systemic environment have
also been recognized to play a role in stem-cell aging
[24]. Muscle stem cells interact with a microenvironment
comprising of myofibers and the basal lamina. Therefore,
the microenvironment of the mdx/SCID mouse skeletal
muscle most likely could not support the effective regen-
eration of the progeroid MDSPCs, reinforcing the impor-
tant role of a healthy microenvironment to promote
successful tissue regeneration.
Notably, the ability of Zmpste24-/- MDSPCs to undergo
myogenic differentiation was rescued after coculture and
in the presence of the WT MDSPC conditioned media.
This result is similar to recent reports showing that WT
MDSPCs rescue differentiation defects of MDSPCs iso-
lated from naturally aged and progeroid ERCC1-deficient
mice when cocultured [30]. These results demonstrate
that dysfunction of progeroid stem cells can be rescued,
at least in part, by exogenous factors secreted by the WT
stem cells. Although the exact secreted factors involved
have yet to be elucidated, several candidate proteins and
signaling pathways are currently under investigation.
Similar results were found in vivo by Conboy and collea-
gues [37] by using parabiosis, in which functional defects
and the regenerative capacity of satellite cells in aged
mice were restored by secreted factors from a young sys-
temic environment. Together, these findings suggest the
possibility of epigenetic changes of stem and progenitor
cells in response to environmental cues. It will be of
great interest to identify the factors secreted by tissue-
specific host cells in response to transplanted donor cells.
Finally, limitation of progeroid MDSPCs to undergo
myogenic differentiation, at least in part, may explain the
muscle atrophy and weakness observed in Zmpste24-/-
progeroid mice. In addition, the reversal of the phenotypic
defects of stem cells with coculture can provide future
opportunities for therapeutic strategies.
Conclusions
The present study demonstrates that MDSPCs isolated
from Zmpste24-/- progeroid mice are defective in their
proliferation and differentiation capabilities in culture
and during tissue regeneration. It remains unclear
whether the defects in MDSPC function arise because of
defects in the stem cells and/or the stem-cell niche.
Therefore, future studies are needed to investigate the
mechanism(s) that confer MDSPC dysfunction with
aging. In addition, myogenic differentiation of defective
MDSPCs was improved after coculturing the cells with
young functional WT MDSPCs. Hence, identifying the
factors secreted by the functional stem cells responsible
for rejuvenation will be valuable for overcoming muscu-
lar degeneration commonly associated with muscular
dystrophies and aging.
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proliferation media; RIPA: radio-immunoprecipitation assay; RNA: ribonucleic
acid; RT-PCR: reverse transcriptase polymerase chain reaction; Sca-1: stem cell
antigen-1; SCID: severe combined immune deficiency; SDS: sodium
dodecylsulfate; TBST: tris-buffered saline tween 20; WT: wild type.
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